乳酸化修饰在肿瘤发展与治疗中的调控机制研究进展
Research Progress in the Regulatory Mechanisms of Lactylation in Tumor Development and Therapy
DOI: 10.12677/acm.2025.1541026, PDF,    科研立项经费支持
作者: 郝庆博, 冯 时, 解维林*:山东第一医科大学(山东省医学科学院)药学院,山东 济南
关键词: 乳酸乳酸化修饰代谢重编程免疫逃逸耐药Lactate Acid Lactylation Modification Metabolic Reprogramming Immune Escape Drug Resistance
摘要: 长期以来,乳酸被认为是缺氧条件下通过糖酵解产生的代谢废物。然而,随着Warburg效应的发现,研究者认识到,即使在有氧条件下,肿瘤细胞依然能通过糖酵解途径产生乳酸。近年来的研究进一步揭示,乳酸不仅在肿瘤代谢重编程中发挥关键作用,还参与了一种新型的表观遗传修饰——乳酸化。乳酸化修饰对基因转录、蛋白质稳定性、代谢重编程、免疫逃逸及耐药性等肿瘤生物学特性产生深远影响。对乳酸化修饰机制的进一步探索,不仅加深了我们对肿瘤发生发展机制的理解,也为癌症治疗策略提供了新的思路。因此,本文总结了乳酸化在癌症研究中的最新进展,深入解析其在肿瘤生物学功能中的作用机制,并探讨其对癌症治疗的应用价值。
Abstract: Traditionally, lactate was considered as a metabolic waste product produced through glycolysis under hypoxic conditions. However, with the discovery of the Warburg effect, it has become evident that tumor cells can produce lactate via the glycolytic pathway even in the presence of oxygen. Recent studies have revealed that lactate not only plays a key role in tumor metabolic reprogramming, but also regulates a novel epigenetic modification known as lactylation. This modification has profound impact on tumor biological properties such as gene transcription, protein stability, metabolic reprogramming, immune escape and drug resistance. With further exploration of the mechanisms of lactylation modification, our understanding of tumorigenesis and progression has been significantly expanded, which provides new ideas for cancer therapeutic strategies. Therefore, this paper summarizes the recent advances of lactylation research in cancer, elucidates its functional mechanisms in tumor biology, and explores its potential implications for therapeutic strategies.
文章引用:郝庆博, 冯时, 解维林. 乳酸化修饰在肿瘤发展与治疗中的调控机制研究进展[J]. 临床医学进展, 2025, 15(4): 1037-1045. https://doi.org/10.12677/acm.2025.1541026

参考文献

[1] Ferguson, B.S., Rogatzki, M.J., Goodwin, M.L., Kane, D.A., Rightmire, Z. and Gladden, L.B. (2018) Lactate Metabolism: Historical Context, Prior Misinterpretations, and Current Understanding. European Journal of Applied Physiology, 118, 691-728. [Google Scholar] [CrossRef] [PubMed]
[2] Warburg, O. (1925) The Metabolism of Carcinoma Cells. The Journal of Cancer Research, 9, 148-163. [Google Scholar] [CrossRef
[3] Chen, L. and Cui, H. (2015) Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach. International Journal of Molecular Sciences, 16, 22830-22855. [Google Scholar] [CrossRef] [PubMed]
[4] Brooks, G.A. (2018) The Science and Translation of Lactate Shuttle Theory. Cell Metabolism, 27, 757-785. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., et al. (2019) Metabolic Regulation of Gene Expression by Histone Lactylation. Nature, 574, 575-580. [Google Scholar] [CrossRef] [PubMed]
[6] Rabinowitz, J.D. and Enerbäck, S. (2020) Lactate: The Ugly Duckling of Energy Metabolism. Nature Metabolism, 2, 566-571. [Google Scholar] [CrossRef] [PubMed]
[7] Liberti, M.V. and Locasale, J.W. (2016) The Warburg Effect: How Does It Benefit Cancer Cells? Trends in Biochemical Sciences, 41, 211-218. [Google Scholar] [CrossRef] [PubMed]
[8] DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007) Beyond Aerobic Glycolysis: Transformed Cells Can Engage in Glutamine Metabolism That Exceeds the Requirement for Protein and Nucleotide Synthesis. Proceedings of the National Academy of Sciences, 104, 19345-19350. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, L., Venneti, S. and Nagrath, D. (2017) Glutaminolysis: A Hallmark of Cancer Metabolism. Annual Review of Biomedical Engineering, 19, 163-194. [Google Scholar] [CrossRef] [PubMed]
[10] Gordan, J.D., Thompson, C.B. and Simon, M.C. (2007) HIF and C-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation. Cancer Cell, 12, 108-113. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, G.L. and Semenza, G.L. (1993) General Involvement of Hypoxia-Inducible Factor 1 in Transcriptional Response to Hypoxia. Proceedings of the National Academy of Sciences, 90, 4304-4308. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Z., Peng, W., Zhang, P., Yang, X. and Zhou, Q. (2021) Lactate in the Tumour Microenvironment: From Immune Modulation to Therapy. EBioMedicine, 73, Article ID: 103627. [Google Scholar] [CrossRef] [PubMed]
[13] Halestrap, A.P. and Wilson, M.C. (2011) The Monocarboxylate Transporter Family—Role and Regulation. IUBMB Life, 64, 109-119. [Google Scholar] [CrossRef] [PubMed]
[14] Zhang, D., Gao, J., Zhu, Z., Mao, Q., Xu, Z., Singh, P.K., et al. (2024) Lysine L-Lactylation Is the Dominant Lactylation Isomer Induced by Glycolysis. Nature Chemical Biology, 21, 91-99. [Google Scholar] [CrossRef] [PubMed]
[15] He, Y., Song, T., Ning, J., Wang, Z., Yin, Z., Jiang, P., et al. (2024) Lactylation in Cancer: Mechanisms in Tumour Biology and Therapeutic Potentials. Clinical and Translational Medicine, 14, e70070. [Google Scholar] [CrossRef] [PubMed]
[16] Xie, B., Zhang, M., Li, J., Cui, J., Zhang, P., Liu, F., et al. (2024) Kat8-Catalyzed Lactylation Promotes eEF1A2-Mediated Protein Synthesis and Colorectal Carcinogenesis. Proceedings of the National Academy of Sciences, 121, e2314128121. [Google Scholar] [CrossRef] [PubMed]
[17] Ju, J., Zhang, H., Lin, M., Yan, Z., An, L., Cao, Z., et al. (2024) The Alanyl-tRNA Synthetase AARS1 Moonlights as a Lactyltransferase to Promote YAP Signaling in Gastric Cancer. Journal of Clinical Investigation, 134, e174587. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, J., Wang, Z., Wang, Q., Li, X. and Guo, Y. (2024) Ubiquitous Protein Lactylation in Health and Diseases. Cellular & Molecular Biology Letters, 29, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[19] Pavlova, N.N., Zhu, J. and Thompson, C.B. (2022) The Hallmarks of Cancer Metabolism: Still Emerging. Cell Metabolism, 34, 355-377. [Google Scholar] [CrossRef] [PubMed]
[20] Epstein, T., Xu, L., Gillies, R.J. and Gatenby, R.A. (2014) Separation of Metabolic Supply and Demand: Aerobic Glycolysis as a Normal Physiological Response to Fluctuating Energetic Demands in the Membrane. Cancer & Metabolism, 2, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[21] Teng, R., Liu, Z., Tang, H., Zhang, W., Chen, Y., Xu, R., et al. (2019) HSP60 Silencing Promotes Warburg-Like Phenotypes and Switches the Mitochondrial Function from ATP Production to Biosynthesis in ccRCC Cells. Redox Biology, 24, Article ID: 101218. [Google Scholar] [CrossRef] [PubMed]
[22] Li, F., Si, W., Xia, L., Yin, D., Wei, T., Tao, M., et al. (2024) Positive Feedback Regulation between Glycolysis and Histone Lactylation Drives Oncogenesis in Pancreatic Ductal Adenocarcinoma. Molecular Cancer, 23, Article No. 90. [Google Scholar] [CrossRef] [PubMed]
[23] Chen, B., Deng, Y., Hong, Y., Fan, L., Zhai, X., Hu, H., et al. (2024) Metabolic Recoding of NSUN2-Mediated m(5)C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m(5)C-ENO1 Positive Feedback Loop. Advanced Science, 11, e2309840. [Google Scholar] [CrossRef] [PubMed]
[24] Zong, Z., Xie, F., Wang, S., Wu, X., Zhang, Z., Yang, B., et al. (2024) Alanyl-tRNA Synthetase, AARS1, Is a Lactate Sensor and Lactyltransferase That Lactylates P53 and Contributes to Tumorigenesis. Cell, 187, 2375-2392.e33. [Google Scholar] [CrossRef] [PubMed]
[25] Zhao, Y., Jiang, J., Zhou, P., Deng, K., Liu, Z., Yang, M., et al. (2024) H3K18 Lactylation-Mediated VCAM1 Expression Promotes Gastric Cancer Progression and Metastasis via AKT-mTOR-CXCL1 Axis. Biochemical Pharmacology, 222, Article ID: 116120. [Google Scholar] [CrossRef] [PubMed]
[26] Li, X., Yang, Y., Jiang, F., Hu, G., Wan, S., Yan, W., et al. (2024) Histone Lactylation Inhibits Rarγ Expression in Macrophages to Promote Colorectal Tumorigenesis through Activation of TRAF6-IL-6-STAT3 Signaling. Cell Reports, 43, Article ID: 113688. [Google Scholar] [CrossRef] [PubMed]
[27] Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., et al. (2022) Lactylation-Driven Mettl3-Mediated RNA m(6)A Modification Promotes Immunosuppression of Tumor-Infiltrating Myeloid Cells. Molecular Cell, 82, 1660-1677.e10. [Google Scholar] [CrossRef] [PubMed]
[28] Cai, Y., Feng, R., Lu, T., Chen, X., Zhou, X. and Wang, X. (2021) Novel Insights into the m(6)A-RNA Methyltransferase METTL3 in Cancer. Biomarker Research, 9, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
[29] Meng, Q., Sun, H., Zhang, Y., Yang, X., Hao, S., Liu, B., et al. (2024) Lactylation Stabilizes DCBLD1 Activating the Pentose Phosphate Pathway to Promote Cervical Cancer Progression. Journal of Experimental & Clinical Cancer Research, 43, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[30] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[31] Bao, C., Ma, Q., Ying, X., Wang, F., Hou, Y., Wang, D., et al. (2025) Histone Lactylation in Macrophage Biology and Disease: From Plasticity Regulation to Therapeutic Implications. eBioMedicine, 111, Article ID: 105502. [Google Scholar] [CrossRef] [PubMed]
[32] Qiao, Q., Hu, S. and Wang, X. (2024) The Regulatory Roles and Clinical Significance of Glycolysis in Tumor. Cancer Communications, 44, 761-786. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, T., Ye, Z., Li, Z., Jing, D., Fan, G., Liu, M., et al. (2023) Lactate‐Induced Protein Lactylation: A Bridge between Epigenetics and Metabolic Reprogramming in Cancer. Cell Proliferation, 56, e13478. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, L. and Li, S. (2020) Lactic Acid Promotes Macrophage Polarization through Mct-Hif1α Signaling in Gastric Cancer. Experimental Cell Research, 388, Article ID: 111846. [Google Scholar] [CrossRef] [PubMed]
[35] Sun, J., Feng, Q., He, Y., Wang, M. and Wu, Y. (2024) Lactate Activates CCL18 Expression via H3K18 Lactylation in Macrophages to Promote Tumorigenesis of Ovarian Cancer. Acta Biochimica et Biophysica Sinica, 56, 1373-1386. [Google Scholar] [CrossRef] [PubMed]
[36] Li, M., Sun, P., Tu, B., Deng, G., Li, D. and He, W. (2024) Hypoxia Conduces the Glioma Progression by Inducing M2 Macrophage Polarization via Elevating TNFSF9 Level in a Histone-Lactylation-Dependent Manner. American Journal of Physiology-Cell Physiology, 327, C487-C504. [Google Scholar] [CrossRef] [PubMed]
[37] Cai, J., Song, L., Zhang, F., Wu, S., Zhu, G., Zhang, P., et al. (2024) Targeting SRSF10 Might Inhibit M2 Macrophage Polarization and Potentiate Anti‐PD‐1 Therapy in Hepatocellular Carcinoma. Cancer Communications, 44, 1231-1260. [Google Scholar] [CrossRef] [PubMed]
[38] Huang, C., Xue, L., Lin, X., Shen, Y. and Wang, X. (2024) Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression. DNA and Cell Biology, 43, 605-618. [Google Scholar] [CrossRef] [PubMed]
[39] Sen, D.R., Kaminski, J., Barnitz, R.A., Kurachi, M., Gerdemann, U., Yates, K.B., et al. (2016) The Epigenetic Landscape of T Cell Exhaustion. Science, 354, 1165-1169. [Google Scholar] [CrossRef] [PubMed]
[40] Grist, J.T., Jarvis, L.B., Georgieva, Z., Thompson, S., Kaur Sandhu, H., Burling, K., et al. (2018) Extracellular Lactate: A Novel Measure of T Cell Proliferation. The Journal of Immunology, 200, 1220-1226. [Google Scholar] [CrossRef] [PubMed]
[41] Klein Geltink, R.I., Kyle, R.L. and Pearce, E.L. (2018) Unraveling the Complex Interplay between T Cell Metabolism and Function. Annual Review of Immunology, 36, 461-488. [Google Scholar] [CrossRef] [PubMed]
[42] Raychaudhuri, D., Singh, P., Chakraborty, B., Hennessey, M., Tannir, A.J., Byregowda, S., et al. (2024) Histone Lactylation Drives CD8+ T Cell Metabolism and Function. Nature Immunology, 25, 2140-2151. [Google Scholar] [CrossRef] [PubMed]
[43] Zeng, Y., Huang, Y., Tan, Q., Peng, L., Wang, J., Tong, F., et al. (2024) Influence of Lactate in Resistance to Anti‑PD‑1/ PD‑L1 Therapy: Mechanisms and Clinical Applications (Review). Molecular Medicine Reports, 31, Article No. 48. [Google Scholar] [CrossRef] [PubMed]
[44] Yao, J., Lin, X., Zhang, X., Xie, M., Ma, X., Bao, X., et al. (2024) Predictive Biomarkers for Immune Checkpoint Inhibitors Therapy in Lung Cancer. Human Vaccines & Immunotherapeutics, 20, Article ID: 2406063. [Google Scholar] [CrossRef] [PubMed]
[45] Ganesh, K., Stadler, Z.K., Cercek, A., Mendelsohn, R.B., Shia, J., Segal, N.H., et al. (2019) Immunotherapy in Colorectal Cancer: Rationale, Challenges and Potential. Nature Reviews Gastroenterology & Hepatology, 16, 361-375. [Google Scholar] [CrossRef] [PubMed]
[46] Tong, H., Jiang, Z., Song, L., Tan, K., Yin, X., He, C., et al. (2024) Dual Impacts of Serine/Glycine-Free Diet in Enhancing Antitumor Immunity and Promoting Evasion via PD-L1 Lactylation. Cell Metabolism, 36, 2493-2510.e9. [Google Scholar] [CrossRef] [PubMed]
[47] Hu, X., Huang, Z. and Li, L. (2024) LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape. Cancer Investigation, 43, 70-79. [Google Scholar] [CrossRef] [PubMed]
[48] Zhang, C., Zhou, L., Zhang, M., Du, Y., Li, C., Ren, H., et al. (2024) H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Research, 84, 3589-3601. [Google Scholar] [CrossRef] [PubMed]
[49] Zhu, X., Zhu, H., Luo, H., Zhang, W., Shen, Z. and Hu, X. (2016) Molecular Mechanisms of Cisplatin Resistance in Cervical Cancer. Drug Design, Development and Therapy, 10, 1885-1895. [Google Scholar] [CrossRef] [PubMed]
[50] Li, J., Chen, Z., Pan, Y. and Zeng, L. (2025) The Important Role of Lactylation in Regulating DNA Damage Repair and Tumor Chemotherapy Resistance. Drug Resistance Updates, 78, Article ID: 101148. [Google Scholar] [CrossRef] [PubMed]
[51] Chen, H., Li, Y., Li, H., Chen, X., Fu, H., Mao, D., et al. (2024) NBS1 Lactylation Is Required for Efficient DNA Repair and Chemotherapy Resistance. Nature, 631, 663-669. [Google Scholar] [CrossRef] [PubMed]
[52] Li, G., Wang, D., Zhai, Y., Pan, C., Zhang, J., Wang, C., et al. (2024) Glycometabolic Reprogramming-Induced XRCC1 Lactylation Confers Therapeutic Resistance in Aldh1a3-Overexpressing Glioblastoma. Cell Metabolism, 36, 1696-1710.e10. [Google Scholar] [CrossRef] [PubMed]
[53] Yue, Q., Wang, Z., Shen, Y., Lan, Y., Zhong, X., Luo, X., et al. (2024) Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2‐Mediated MLH1 Intron Retention. Advanced Science, 11, e2309290. [Google Scholar] [CrossRef] [PubMed]
[54] Li, W., Zhou, C., Yu, L., Hou, Z., Liu, H., Kong, L., et al. (2023) Tumor-Derived Lactate Promotes Resistance to Bevacizumab Treatment by Facilitating Autophagy Enhancer Protein RUBCNL Expression through Histone H3 Lysine 18 Lactylation (h3k18la) in Colorectal Cancer. Autophagy, 20, 114-130. [Google Scholar] [CrossRef] [PubMed]
[55] Chen, J., Zhao, D., Wang, Y., Liu, M., Zhang, Y., Feng, T., et al. (2024) Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis (Adv. Sci. 38/2024). Advanced Science, 11, e2406333. [Google Scholar] [CrossRef
[56] Lu, Y., Zhu, J., Zhang, Y., Li, W., Xiong, Y., Fan, Y., et al. (2024) Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA M6a—Modification Promotes Lenvatinib Resistance in HCC. Advanced Science, 11, e2401399. [Google Scholar] [CrossRef] [PubMed]